Immunological factors and liver fibrosis in pediatric liver transplant recipients

Annals of Transplantation

Volumn 20, Issue , 2015, Pages 279-284

  Markiewicz Kijewska, Małgorzata ^a   Kaliciński, Piotr ^a   Kluge, Przemysław ^a   Piątosa, Barbara ^a   Jankowska, Irena ^a   Rękawek, Aneta ^a   Kostecka, Ewa ^a   Kurowski, Przemysław N ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Child; Fibrosis; Liver transplantation

Indexed keywords

ACUTE GRAFT REJECTION; ANTIBODY MEDIATED REJECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL PARAMETERS; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; CHILD; FEMALE; GRAFT REJECTION; IMMUNOLOGY; INFANT; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PATHOLOGY; PRESCHOOL CHILD;

AUTOANTIBODY; HLA ANTIGEN;

AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; INFANT; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; RETROSPECTIVE STUDIES;

EID: 84933533902     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.892544     Document Type: Article

References (15)

1. Slapak GI, Saxena R, Portmann B et al: Graft and systemic disease in long term survivors of liver transplantation. Hepatology, 1997; 25: 195-202
2. Martin SR, Russo P, Dubois J, Alverez F: Centrilobular fibrosis in long-term follow-up of pediatric liver transplant recipients. Transplantation, 2002; 74: 828-38
3. Scheenstra R, Peeters PMGJ, Verkade HJ, Gouw ASH: Graft fibrosis after pediatric liver transplantation: ten years follow-up. Hepatology, 2009; 49: 880-86
4. Rosenthal P, Emond JC, Heyman MB et al: Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. Liver Transpl Surg, 1997; 3: 559-62
5. Magee JC: Graft Fibrosis in stable pediatric liver transplant recipients: what does it mean? Hepatology, 2009; 49: 726-28
6. Ekong UD, Melin-Aldana H, Sesehadri R et al: Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl, 2008; 14: 1582-87
7. Venturi C, Reding R: Long-term liver allograft fibrosis in children: more questions than answers. Pediatric Transpl, 2011; 15: 449-50
8. Miyagawa-Hayaschino A, Yoshizawa A, Uchida Y et al: Progressive graft fibrosis and donor specific human leukocyte antigens antibodies in pediatric late liver allografts. Liver Transpl, 2012; 18: 1333-42
9. Markiewicz-Kijewska M, Kalicinski P, Kluge P et al: Study on antibody mediated rejection in pediatric liver transplant recipients. Ann Transplant, 2014; 19: 119-23
10. Herman GE, Elfont EA: The taming of immunohistochemistry: the new era of quality of control. Biotech Histochem, 1991; 66: 194-99
11. Naish SJ: Handbook-immunochemical staining methods. Carpinteria: DAKO Corporation 1989
12. Goodman ZD: Grading and staging system for inflammation and fibrosis in chronic liver disease. J Hepatol, 2007; 47: 598-607
13. Hubscher S: What does the long-term liver allograft look like for the pediatric recipient? Liver Transpl, 2009; 15: S19-24
14. Evans HM, Kelly DA, Mckiernan PJ, Hubscher S: Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology, 2006; 43: 1109-17
15. Kosola S, Lampela H, Jalanko H et al: Low-dose steroids associated with milder histological changes after pediatric liver transplantation. Liver Transpl, 2013; 19: 145-54